Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating androgen suppression with nodal irradiation and dose-escalated prostate radiotherapy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Androgen deprivation therapy (ADT) (Androgen deprivation therapy)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Prostate Cancer | Phase 3 | Status: RECRUITING